Clinical Trial Update: Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating lonafarnib in combination with temozolomide for patients with recurrent primary supratentorial gliomas.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms
• Glioma

Drugs mentioned

• Lonafarnib (lonafarnib)
• Temozolomide (Temozolomide)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: UNKNOWN